JIABO is intensifying investment in innovative drug R&D, with several candidates in the pipeline, aiming to elevate drug quality and address unmet medical needs.

By expanding product reserves, increasing production capacity, and optimizing product structures, JIABO is enriching its portfolio and strengthening intellectual property protection for both products and R&D technologies. These efforts are building JIABO’s unique competitive edge in the pharmaceutical industry.

By integrating cutting-edge technology and rigorous quality standards, JIABO sets benchmarks in the domestic industry while leveraging its advanced capabilities to enter SRA international markets, reinforcing its commitment to global compliance and excellence.
Quality First Principle: JIABO upholds its core philosophy of ‘Quality First’, ensuring strict compliance with domestic Drug Administration Laws and GMP standards.
Consistent Excellence: The company has achieved a 100% pass rate for all released products, reflecting its unwavering commitment to quality control.
State-of-the-Art Facilities: With a newly built production line that meets EU/FDA/WHO GMP standards, enabling the production of high-quality pharmaceutical products.

Solution for perioperative products delivers exceptional efficiency, convenience, and cost-effectiveness. The comprehensive product range includes general anesthetics, local anesthetics, muscle relaxants, anticholinergics, vasopressors, parenteral nutrition, and more, covering all essential needs throughout the perioperative period.

By streamlining procurement processes, JIABO simplifies purchasing for healthcare providers, reduces supply chain complexities, and enhances inventory management. This integrated approach ensures reliable access to high-quality perioperative products while optimizing operational efficiency.

JIABO’s vertical integration of APIs and FDFs enhances efficiency, reduces costs, and strengthens supply chain stability. This integrated approach ensures consistent quality and reliable production of pharmaceutical products.

With an annual production capacity of 100 million units for small-volume injectables, JIABO meets high demand efficiently, maintaining competitive pricing. This large-scale capability positions JIABO as a key supplier for domestic tender bids, ensuring cost-effectiveness and market competitiveness.

JIABO has a clear and focused strategy for international market penetration, with steady progress in EU projects and a strong emphasis on high-end regulatory markets. The key elements of our strategy include: